- Home
- G vs RGC Comparison
G vs RGC Comparison
Compare G & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | G | RGC |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | Bermuda | Hong Kong |
| Employees | N/A | N/A |
| Industry | Professional Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 8.4B |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | G | RGC |
|---|---|---|
| Price | $46.35 | $16.05 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $50.33 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 205.9K |
| Earning Date | 11-06-2025 | 10-24-2025 |
| Dividend Yield | ★ 1.48% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.10 | N/A |
| Revenue | ★ $5,009,342,000.00 | N/A |
| Revenue This Year | $7.49 | N/A |
| Revenue Next Year | $6.71 | N/A |
| P/E Ratio | $14.84 | ★ N/A |
| Revenue Growth | ★ 7.39 | N/A |
| 52 Week Low | $37.49 | $0.09 |
| 52 Week High | $56.76 | $83.60 |
Technical Indicators
Market Signals| Indicator | G | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 70.22 | 61.51 |
| Support Level | $43.75 | $10.50 |
| Resistance Level | $45.21 | $18.15 |
| Average True Range (ATR) | 0.81 | 1.54 |
| MACD | 0.11 | 0.57 |
| Stochastic Oscillator | 90.22 | 73.17 |
Price Performance
Historical ComparisonAbout G Genpact Limited
Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. It is a General Electric spin-off, which is still a large source of revenue for Genpact.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.